Search Results for: PATH
Sirius XM has seen a very muted reaction to what should have been otherwise viewed as a solid earnings report.
Published:
Last Updated:
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
Published:
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Published:
Paychex reported better-than-expected first-quarter fiscal 2015 results before markets opened Wednesday morning.
Published:
Last Updated:
Source: ThinkstockMolycorp Inc. (NYSE: MCP) saw its shares take another solid leap in Friday’s trading to above the $1 mark. This is potentially a huge development for the company and a big first...
Published:
By John Tamny of RealClearMarkets A recent survey of economists in the Wall Street Journal pointed to economic recovery beginning in September. The problem here is that true economic growth is about...
Published:
Source: Jon OggEastman Kodak Co. (EKDKQ) is just about to be a new company, with a new direction under the same CEO, and without the burdens of its financial disaster of a past. This story has felt...
Published:
Canaccord Genuity reiterated its Buy rating on Boeing on Thursday, while lifting the price target for the stock. And before the broad market sell-off on Thursday, Boeing shares hit an all-time high.
Published:
Honeywell International reported mixed first-quarter 2015 results before markets opened Friday morning.
Published:
Last Updated:
On Tuesday morning we’ll get to see earnings out of Staples, Inc. (NASDAQ: SPLS). The estimates for the office supplier from First Call are $0.47 EPS on $5.37 billion in revenues. Next...
Published:
Pfizer Inc. (NYSE: PFE) has given some of its basic data points for its analyst meeting today. For starters, the company has reaffirmed its guidance for 2008 that it previously offered. ...
Published:
Last Updated:
Verizon and Straight Path Communications have agreed to a $3.1 billion deal in which Verizon will acquire the smaller company. Straight Path owns spectrum licenses that are vital to the coming...
Published:
Last Updated:
New York activist shareholder Slate Path Capital has disclosed a 7.16 million share, or 16.5% stake, in Cyclerion Therapeutics.
Published:
Shortly after noon ET today, the three major US stock indexes have reversed course from their higher openings. The DJIA up more than 15 points at around13,193, the Nasdaq down less than 1 point at...
Published: